- Keurig Dr Pepper’s fourth-quarter adjusted earnings per share (EPS) was 58 cents, slightly beating the estimate of 57 cents.
- Net sales reached $4.07 billion, surpassing the expected $4.01 billion.
- In the US Refreshment Beverages segment, net sales were $2.4 billion, higher than the projected $2.36 billion.
- US Coffee net sales came in at $1.1 billion, slightly below the estimate of $1.13 billion.
- International net sales totaled $500 million, which was below the estimate of $523 million.
- Net price realization at constant currency increased by 0.9%.
- Overall volume/mix at constant currency rose by 5.3%, exceeding the estimate of 4.34%.
- The change in US Refreshment Beverages volume/mix was 7.5%, compared to an estimate of 3.65%.
- US Coffee volume/mix increased by 0.7%, underperforming the estimate of 2.30%.
- International volume/mix at constant currency improved by 6.5%, slightly above the estimate of 6.43%.
- Adjusted operating income matched expectations at $1.13 billion.
- The company anticipates net sales growth in the mid-single-digit range for 2025.
- Adjusted EPS growth for 2025 is projected to be in the high-single-digit range on a constant currency basis.
- Foreign currency translation is expected to be a one to two percentage point headwind to full-year growth at current rates.
Keurig Dr Pepper on Smartkarma
Analyst coverage of Keurig Dr Pepper on Smartkarma includes a detailed report by Baptista Research. The report, titled “Keurig Dr Pepper (KDP): The Tale Of Brewer Innovation and Market Expansion To Up Their Game! – Major Drivers,” analyzes the company’s recent earnings report for the third quarter of 2024. In the report, CEO Timothy Cofer and CFO Sudhanshu Priyadarshi discuss promising advancements along with areas needing improvement. Baptista Research assesses various factors that could impact the company’s stock price in the near future and conducts an independent valuation using a Discounted Cash Flow (DCF) methodology.
A look at Keurig Dr Pepper Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Keurig Dr Pepper, a company known for manufacturing and distributing a variety of non-alcoholic beverages, has been assessed using Smartkarma Smart Scores to provide insights into its long-term outlook. With a solid overall outlook indicated by scores of 3 for Value, 4 for Dividend, 4 for Growth, 3 for Resilience, and 3 for Momentum, the company appears to be on a promising trajectory.
Driven by positive evaluations in Dividend and Growth, Keurig Dr Pepper seems positioned to deliver value to investors over the long term. Additionally, its resilience score reflects a foundation that is well-prepared to navigate potential challenges. While momentum may not be the highest, the company’s strong performance in other areas suggests a steady path forward. Serving customers across the United States, Canada, and Mexico, Keurig Dr Pepper continues to maintain its presence in the non-alcoholic beverage market with a promising outlook.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
